# FDA recall Z-0473-2023

> **Becton Dickinson & Co.** · Class II · device recall initiated 2022-11-21.

## Product

BBL Chocolate II Agar-  IVD for the isolation and cultivation of Neisseria species.  Catalog (Ref) Number: 221267

## Reason for recall

Boxes contain a reduced concentration of Nicotinamide Adenine Dinucleotide and does not provide enough of the blood factors necessary to support Haemophilus growth. The reduction could cause a false negative result for Haemophilus isolation in a clinical specimen.

## Distribution

Worldwide distribution - US Nationwide and the countries of Canada, India, Philippines.

## Key facts

- **Recall number:** Z-0473-2023
- **Recalling firm:** Becton Dickinson & Co.
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2022-11-21
- **Report date:** 2022-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sparks, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0473-2023

## Citation

> AI Analytics. FDA recall Z-0473-2023. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/Z-0473-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*